David Linn is the co-founder of Cycle for Survival, the movement to beat rare cancers. Cycle for Survival has raised more than $340 million to support pioneering research and lifesaving clinical trials at Memorial Sloan Kettering Cancer Center (MSK), bringing new and better treatment options to people around the world. In addition to David’s active involvement with Cycle for Survival, he is an EVP and Board Member at Oak Point Partners.
Read More